RNS Number : 8565U
Marwyn Acquisition Company II Ltd
02 July 2024
 

2 July 2024

MARWYN ACQUISITION COMPANY II LIMITED ("COMPANY" OR "MAC II")

PDMR DEALING NOTIFICATION

A notification in respect of PDMR dealings in accordance with the requirements of Article 19 of the UK version of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, is set out below.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Marwyn Investment Management LLP, a person closely associated with James Corsellis (a director of the Company) and Antoinette Vanderpuije (Company Secretary of the Company)

2

Reason for the notification

a)

Position/status

 

Investment Manager of the Marwyn funds.

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marwyn Acquisition Company II Limited

b)

LEI

2549008KZ7HM27V4O637

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of no par value

b)

Nature of the transaction

Acquisition by funds managed by Marwyn Investment Management LLP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.00 per ordinary share

16,688,667

d)

Aggregated information

-

Aggregated volume

-

Price

N/A

e)

Date of the transaction

28 June 2024

f)

Place of the transaction

London Stock Exchange

 

 

Enquiries

Company Secretary

Antoinette Vanderpuije - 020 7004 2700

FGS Global

Rollo Head / Chris Sibbald / Sophia Johnston

Tel: + 44 (0) 20 7251 3801

Marwyn-LON@fgsglobal.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHELLFBZDLXBBV